ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Irinotecan Accord 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung - 
66766003 Accord Healthcare AG
Irinotecan Accord 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung24.09.2018
Generic24.09.2018
Irinotecan (L01CE02) 
WHO-DDD 
07.16.10. 
07.16.10. 
A  
Yes 
IP 
245.64No
    
10 %283.55
  
7680667660033Synthetika
7606237 
Composition
irinotecani hydrochloridum trihydricum 300 mg, acidum lacticum, sorbitolum 675 mg, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 15 ml corresp. natrium max. 1.21 mg.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Irinotecan Hydrochloride Trihydrate300mg / 15ml
BAG: Active AgentDose
Irinotecan Hydrochloride Trihydrate300 mg
 
Inactive agentsDose
Acidum Hydrochloridum 
Lactic Acid 
Sodium Hydroxide 
Sorbitol675mg / 15ml
 
Source
Data was imported : 04.05.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home